571 related articles for article (PubMed ID: 16431335)
21. Inflammatory and toxic myopathies.
Dalakas MC
Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):645-54. PubMed ID: 1327303
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
24. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
[TBL] [Abstract][Full Text] [Related]
25. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
26. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
27. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
28. Tenascin is a useful marker in the diagnosis of inflammatory myopathies.
Müller-Felber W; Toepfer M; Müller T; Müller-Höcker J; Fischer P; Lochmüller H; Pongratz D
Eur J Med Res; 1998 Jun; 3(6):281-7. PubMed ID: 9620889
[TBL] [Abstract][Full Text] [Related]
29. Dermatomyositis with inclusion body myositis pathology.
Layzer R; Lee HS; Iverson D; Margeta M
Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
[TBL] [Abstract][Full Text] [Related]
30. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
31. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
Figarella-Branger D; Civatte M; Bartoli C; Pellissier JF
Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
[TBL] [Abstract][Full Text] [Related]
32. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
33. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
De Paepe B; Creus KK; De Bleecker JL
Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
[TBL] [Abstract][Full Text] [Related]
34. Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies.
Macaione V; Aguennouz M; Mazzeo A; De Pasquale MG; Russo M; Toscano A; De Luca G; Di Giorgio RM; Vita G; Rodolico C
Acta Neurol Scand; 2008 Jun; 117(6):393-8. PubMed ID: 18005224
[TBL] [Abstract][Full Text] [Related]
35. [Expression of ICAM-1 and VCAM-1 in human ameloblastoma and odontogenic keratocyst].
Wang J; Zhong M; Zhang LZ; Wang Y; Wang ZY
Shanghai Kou Qiang Yi Xue; 2003 Aug; 12(4):273-6. PubMed ID: 14966640
[TBL] [Abstract][Full Text] [Related]
36. Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.
Schleinitz N; Cognet C; Guia S; Laugier-Anfossi F; Baratin M; Pouget J; Pelissier JF; Harle JR; Vivier E; Figarella-Branger D
Arthritis Rheum; 2008 Oct; 58(10):3216-23. PubMed ID: 18821690
[TBL] [Abstract][Full Text] [Related]
37. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
38. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
39. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
40. The influence of propofol on the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in reoxygenated human umbilical vein endothelial cells.
Corcoran TB; Engel A; Shorten GD
Eur J Anaesthesiol; 2006 Nov; 23(11):942-7. PubMed ID: 16834788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
